Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

VRTXVRTX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in VERTEX PHARMACEUTICALS INC

JPMORGAN CHASE & CO holds 6.5M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $3.3B as of 2026-Q2. The position was decreased (-7.3% shares). VRTX represents 0.2% of JPMORGAN CHASE & CO's portfolio.

Current Value

$3.3B

Current Shares

6.5M

Total Value Change

+$714.2M

Total Shares Change

+204,493

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.5M
-7.3%
$3.3B0.2%$496.73
0
2026-Q1
Increased
7M
+16.4%
$3.1B0.2%$474.27
44
2025-Q4
Decreased
6M
-53.1%
$2.7B0.2%$453.74
0
2025-Q3
Increased
12.9M
+119.3%
$5B0.2%$395.31
62
2025-Q2
Decreased
5.9M
-24.3%
$2.6B0.2%$441.30
0
2025-Q1
Increased
7.8M
+22.9%
$3.8B0.3%$492.69
46
2024-Q4
New
6.3M
-
$2.5B0.2%$399.35
53

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used